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Background
The valine to glutamate substitution at codon 600 in exon
15 of the BRAF gene (V600E) is the major driver mutation
in papillary thyroid carcinomas (PTCs). Contribution of
genomic gains and losses to onset and progression of PTC
is far less known. We assessed genomic imbalances in
PTCs by utilizing high-density oligonucleotide arrays.
Materials and methods
We used SurePrint G3 human CGH+SNP, 2×400K,
microarrays to assess gains and losses in 47 PTCs in
comparison to male and female human reference DNA.
Interpretation of results was accomplished by using the
HG19 version of the design file and the default analysis
method of the Cytogenomics 2.7 research software [1].
To compare BRAF mutant (BRAFmut) PTCs with BRAF
wild type (BRAFwt) PTCs, the BRAF mutational status
was established in 42 cases by direct sequencing the
mutational hotspot region in exon 15 [2].
Results
Whole chromosome/chromosome arm imbalances (e.g.,
-1p, -16q, -19) were only infrequently observed and one
case was in the triploid stage. The predominant forms
of imbalances were microdeletions that were in general
more pronounced in both BRAFmut PTCs (N=27) and
BRAFwt PTCs (N=15). These microdeletions, observed
in ∽40% or more of the cases, include known and yet
unknown thyroid cancer susceptibility genes, for exam-
ple TAF12 & RCC1 (1p, 28.8~28.9 Mb) YY1AP1
(1q, 155.7 Mb), PRKCI (2q, 169.9 Mb), GSTM2P1 &
RPF2 & GTF3C6 & CDK19 (8q, 110.9~111.1 Mb),
RASSF3 & TBK1 (12q, 64,5~65.2 Mb), MDM2 &
NUP107 & RAP1B (12q, ~69.0~69.2 Mb), BRCA1 &
NAGLU (17q, 40.6~41.1 Mb), and CDH2 (18q, ~25.5
Mb). Microamplifications, observed in ∽30% or more of
the cases, include genes as USH2A (1q, 216.5 Mb),
CTNNA2 (2p, 79.9 Mb), CLSTN2 (2q, 139.9 Mb),
MSR1 (8p, 16.0 Mb), and CASP12 (11q, 104.6 Mb).
Number and extent of regions with SNP homozygosity
varied widely between the cases.
Conclusions
This is one of the first studies using high-density oligonu-
cleotide arrays to survey chromosomal imbalances in
conventional BRAFmut and BRAFwt PTCs enabling
to detect microdeletions/microamplifications (usually
< 1 Mb) affecting known or yet unknown genes related to
thyroid cancer. Further studies have to reveal how the
affected genes contribute to onset and/or progression of
PTC besides the known implication of the BRAF gain-of-
function mutation in this disease.
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